The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Decode the Crosstalk Between Bones, Brain, and Fat

Decode the Crosstalk Between Bones, Brain, and Fat

April 1, 2010 • By Kathy Holliman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Philadelphia—Discovery of a leptin–serotonin pathway to regulate appetite and bone mass accrual is providing valuable insight into bone disease and may open new pathways to therapy.

You Might Also Like
  • Sensory Nerves May Be Key for Osteoporosis
  • Orexin’s Yin/Yang Functions Regulate Bone Remodeling
  • Insight into Crosstalk Between Bone & Immune Systems
Explore This Issue
April 2010
Also By This Author
  • New Bisphosphonate Therapy Recommendations for Postmenopausal Osteoporosis

Gerard Karsenty, MD, PhD, chair of the department of genetics and development at Columbia University’s College of Physicians and Surgeons in New York, said that this research is a good example of how physiology “has been more changed by mouse genetics than any other field.” He delivered the Hench Society Lecture here at the ACR/ARHP Annual Scientific Meeting in October 2009. Each year, the Hench Society Lecture honors the contributions of Philip S. Hench, MD, the co-winner of the 1950 Nobel Prize in Medicine, for his work on cortisone.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In his lecture, Dr. Karsenty reviewed several steps in the research with mouse models that were published in the journal Cell.1 This research, he said, underscored the concept that, “for every physiological function, there is more than one organ involved.”

Leptin molecule.
Leptin molecule.

Although clinical applications await future investigation, the current research adds to understanding of the apparent association of obesity with a lower incidence of osteoporosis. It may open up new avenues for research into the development of osteoporosis in people treated with selective serotonin reuptake inhibitors (SSRIs). Dr. Karsenty noted two important clinical observations that prompted this avenue of research: “Obesity invariably follows gonadal failure, and obesity protects from osteoporosis.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Understanding Bone Remodeling

Research conducted by Dr. Karsenty and colleagues in 2007 had identified the skeleton as an organ of the endocrine system that helps regulate glucose metabolism. In that research, also published in Cell, they reported that bone cells release osteocalcin.2 “By revealing that the skeleton exerts endocrine regulation of sugar homeostasis, this study expands the biological importance of this organ and our understanding of energy metabolism,” they wrote.

According to Dr. Karsenty’s presentation at the meeting, there are two defining features of the physiology of the skeletal system. One is that the skeleton, with the skin and muscle, is an organ covering the largest surface of the body. Additionally, and somewhat surprisingly, bone contains a cell, the osteoclast, whose main function is to constantly destroy bone.

It is now understood that leptin regulates the homeostatic function of bone remodeling in humans and in mice, a process that includes both bone resorption and bone formation. The original purpose of bone remodeling during evolution was the repair of micro and macro damage, or fractures. “It was a survival function,” Dr. Karsenty said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions Tagged With: bone remodeling, Genes, leptin, leptin–serotonin pathway, Osteoporosis, ResearchIssue: April 2010

You Might Also Like:
  • Sensory Nerves May Be Key for Osteoporosis
  • Orexin’s Yin/Yang Functions Regulate Bone Remodeling
  • Insight into Crosstalk Between Bone & Immune Systems
  • Researchers Probe the Role of Fat Cells in Inflammation

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.